id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-292180-sjmeyhan	Guzman-Prado, Yuli	Retraction of studies on potential drug therapies for COVID-19: A call for reliability and scientific integrity	2020-06-30		.txt	text/plain	549	26	42	The author of this paper recently discussed the findings on cardiovascular safety of the controversial use of chloroquine (CQ) and hydroxychloroquine (HCQ) for the treatment of COVID-19 reported in observational studies, stressing the need of high quality large randomized controlled trials in order to assess the effectiveness and safety of these drugs and other potential therapies for COVID-19 One of the commented studies (2) , which reported a decrease in the in-hospital survival and an increased frequency of de-novo ventricular arrhythmias with the use of CQ or HCQ, was recently retracted by three of the four authors, causing controversy in the scientific community and raising serious concerns on the reliability of published papers and the transparency and accountability of researchers particularly in the midst of this global health crisis. Likewise, a different study conducted by Mehra, et al (3) assessed the relationship of cardiovascular disease and drug therapy with in-hospital mortality among patients with COVID-19.	./cache/cord-292180-sjmeyhan.txt	./txt/cord-292180-sjmeyhan.txt